FDA adds some fresh senior leadership with new chief scientist, chief medical officer
While the FDA is typically known for its ever-expanding hiring needs, thanks to an industry where top scientists can make double or triple in the private industry versus the FDA, commissioner Rob Califf on Thursday announced two new leaders at the agency.
Johns Hopkins’ Namandjé Bumpus will be the FDA’s new chief scientist, replacing Denise Hinton, who moved on in October 2021 to advise and support the US Surgeon General, and Hilary Marston, a White House senior policy advisor on Covid-19, will take over as chief medical officer, which was a role previously held by Janet Woodcock.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
